LINC00184 Promotes Ovarian Cancer Cells Proliferation and Cisplatin Resistance by Elevating CNTN1 Expression via Sponging miR-1305
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Reference40 articles.
1. LncRNAs in ovarian cancer
2. Long non-coding RNA ENST00000457645 reverses cisplatin resistance in CP70 ovarian cancer cells
3. Cyclin A1 expression and paclitaxel resistance in human ovarian cancer cells
4. PLGA nanoparticles co-delivering MDR1 and BCL2 siRNA for overcoming resistance of paclitaxel and cisplatin in recurrent or advanced ovarian cancer
5. Valproic Acid Promotes Apoptosis and Cisplatin Sensitivity Through Downregulation of H19 Noncoding RNA in Ovarian A2780 Cells
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis;2024-05-08
2. Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death;Cells;2024-02-23
3. CircSFMBT2 Plays an Oncogenic Role in Lung Adenocarcinoma Depending on the miR-1305/SALL4 Axis;Biochemical Genetics;2023-12-21
4. LncRNA PART1 Regulates Ovarian Carcinoma Development via the miR-150-5p/MYB Axis;Frontiers in Bioscience-Landmark;2023-10-27
5. Identification of lncRNAs Deregulated in Epithelial Ovarian Cancer Based on a Gene Expression Profiling Meta-Analysis;International Journal of Molecular Sciences;2023-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3